MAM
CLVS
Morse Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-13,400
| Closed | -$609K | – | 142 |
|
|
2018
Q2 | $609K | Buy |
13,400
+1,650
| +14% | +$75K | 0.17% | 101 |
|
|
2018
Q1 | $620K | Buy |
11,750
+7,100
| +153% | +$375K | 0.17% | 101 |
|
|
2017
Q4 | $316K | Sell |
4,650
-24,270
| -84% | -$1.65M | 0.09% | 115 |
|
|
2017
Q3 | $2.38M | Buy |
+28,920
| New | +$2.38M | 0.71% | 49 |
|